2022
DOI: 10.1007/s00246-022-03052-2
|View full text |Cite
|
Sign up to set email alerts
|

Longitudinal Cardiac Outcomes of Multisystem Inflammatory Syndrome in Children: A Systematic Review and Meta-Analysis

Abstract: There is a paucity of longitudinal data on cardiac outcomes in multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19. We aimed to investigate the longitudinal cardiovascular outcomes in MIS-C. PubMed and EMBASE were searched through May 2022. Observational studies were included, reporting mid-term (≥ 3 months) outcomes in children (aged < 21) with MIS-C. Data were extracted by two researchers. Longitudinal outcomes were synthesized by a one-group meta-analysis using a random-effects mo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(9 citation statements)
references
References 62 publications
2
4
0
Order By: Relevance
“…The results of our study are in line with most of the previous findings and show that valvular insufficiency and myocardial dysfunction are the most common cardiological findings in children with MIS-C. The median LVEF in our study (55%) was comparable with the results presented in the meta-analysis of the studies concentrating on longitudinal cardiac outcomes in MIS-C (54%) [47]. IMV was slightly less common in our study (42.8% vs. 56.6%) and CAAs were definitively less common (10.5% vs. 23.7%) [47].…”
Section: Discussionsupporting
confidence: 92%
See 2 more Smart Citations
“…The results of our study are in line with most of the previous findings and show that valvular insufficiency and myocardial dysfunction are the most common cardiological findings in children with MIS-C. The median LVEF in our study (55%) was comparable with the results presented in the meta-analysis of the studies concentrating on longitudinal cardiac outcomes in MIS-C (54%) [47]. IMV was slightly less common in our study (42.8% vs. 56.6%) and CAAs were definitively less common (10.5% vs. 23.7%) [47].…”
Section: Discussionsupporting
confidence: 92%
“…The median LVEF in our study (55%) was comparable with the results presented in the meta-analysis of the studies concentrating on longitudinal cardiac outcomes in MIS-C (54%) [47]. IMV was slightly less common in our study (42.8% vs. 56.6%) and CAAs were definitively less common (10.5% vs. 23.7%) [47]. Such a discrepancy in the frequency of CAAs was noted before in our population [37] and may be explained by ethnic differences.…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…Finally, a systematic review and meta-analysis performed by Yasuhara et al revealed the longitudinal cardiac outcomes in MIS-C patients based on their mid-term (>3 months) follow-ups. The authors emphasized the importance of follow-up with these patients, observing a decrease in the rate of LV systolic dysfunction (from 46.8% at admission to 1.7% after 3 months and 2.1% after 6 months), coronary abnormalities (from 23.7% to 4.7% and 5.2%, in 3 and 6 months, respectively), and mitral regurgitation (from 56.6% to 7.5% at the 6th month) [58].…”
Section: Discussionmentioning
confidence: 99%
“…Regarding children hospitalized with MIS-C, the impairments described for this cohort represent sequelae of a post-infectious complication of COVID, which is not considered “long COVID” but remains an important outcome for children infected with SARS-CoV-2. While cardiac abnormalities are likely to resolve during the post-acute recovery period, the trajectory of the multisystem impairments requires further investigation ( 38 ).…”
Section: Discussionmentioning
confidence: 99%